BRCA1-hapoinsufficiency: Unraveling the molecular and cellular basis for tissue-specific cancer

Cell Cycle

Volumn 15, Issue 5, 2016, Pages 621-627

  Sedic, Maja ^a,b   Kuperwasser, Charlotte ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

BRCA1; haploinsufficiency; tumor suppression

Indexed keywords

BRCA1 PROTEIN; BRCA1 PROTEIN, HUMAN;

ALLELE; BREAST CANCER; BREAST EPITHELIUM CELL; CANCER RISK; GENE MUTATION; GENE PRODUCT; GENOMIC INSTABILITY; HAPLOINSUFFICIENCY; HETEROZYGOSITY LOSS; HUMAN; ONCOGENE; OVARY CANCER; PHENOTYPE; REVIEW; TISSUE SPECIFICITY; ANIMAL; ANTIBODY SPECIFICITY; BREAST TUMOR; FEMALE; GENETICS; MAMMARY GLAND; MUTATION; OVARY TUMOR; PATHOLOGY; TUMOR SUPPRESSOR GENE;

ANIMALS; BRCA1 PROTEIN; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; HAPLOINSUFFICIENCY; HUMANS; MAMMARY GLANDS, HUMAN; MUTATION; ORGAN SPECIFICITY; OVARIAN NEOPLASMS;

EID: 84962030747     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.1080/15384101.2016.1141841     Document Type: Review

References (73)

1. S.A.Narod, W.D.Foulkes. BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer 2004; 4:665-76; PMID:15343273; http://dx.doi.org/10.1038/nrc1431
2. K.Yoshida, Y.Miki. Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell-cycle in response to DNA damage. Cancer Sci 2004; 95(11):866-71; PMID:15546503; http://dx.doi.org/10.1111/j.1349-7006.2004.tb02195.x
3. J.Zhang, S.N.Powell. The role of the BRCA1 tumor suppressor in DNA double-strand break repair. Mol. Cancer Res. 2005; 3(10):531; PMID:16254187
4. C.X.Deng. BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. Nucleic Acids Res 2006; 34(5):1416-26; PMID:16522651; http://dx.doi.org/10.1093/nar/gkl010
5. M.S.Y.Huen, S.M.H.Sy, J.Chen. BRCA1 and its toolbox for the maintenance of genome integrity. Nat Rev Mol Cell Bio 2010; 11:136-48; http://dx.doi.org/10.1038/nrm2831
6. K.I.Savage, D.P.Harkin. BRCA1, a “complex” protein involved in the maintenance of genomic stability. FEBS J 2015; 282:630-46; PMID:25400280; http://dx.doi.org/10.1111/febs.13150
7. S.L.Clark, A.M.Rodriguez, R.R.Snyder, G.D.V.Hankins, D.Boehning. Structure-Function of the Tumor Supressor BRCA1. Computational Struct Biotechnol J 2012; 1(1):e201204005; PMID:22737296; http://dx.doi.org/10.5936/csbj.201204005
8. R.Roy, J.Chun, S.N.Powell. BRCA1 and BRCA2: different roles in a common pathway of genome protection. Nat Rev 2012; 12:68-78; http://dx.doi.org/10.1038/nrc3181
9. P.J.O’Donovan, D.M.Livingston. BRCA1 and BRCA2: breast/ovarian cancer susceptibility gene products and participants in DNA double-strand break repair. Carcinogenesis 2010; 31(6):961-7; http://dx.doi.org/10.1093/carcin/bgq069
10. S.M.Dever, E.R.White, M.C.T.Hartman, K.Valerie. BRCA1-directed, enhanced and aberrant homologous recombination. Cell Cycle 2012; 11(4):687-94; PMID:22306997; http://dx.doi.org/10.4161/cc.11.4.19212
11. J.Zhang. The role of BRCA1 in homologous recombination repair in response to replication stress: significance in tumorigenesis and cancer therapy. Cell Biosci 2013; 3:11
12. R.Scully, D.M.Livingston. In search of the tumor-suppressor functions of BRCA1 and BRCA2. Nature 2000; 408:429-32; PMID:11100717; http://dx.doi.org/10.1038/35044000
13. A.Tutt, A.Ashworth. The relationship between the roles of BRCA genes in DNA repair and cancer predisposition. Trends Mol Med 2002; 8(12):571-6; PMID:12470990; http://dx.doi.org/10.1016/S1471-4914(02)02434-6
14. D.P.Silver, D.M.Livingston. Mechanisms of BRCA1 tumor suppression. Cancer Discov 2012; 2:679-84; PMID:22843421; http://dx.doi.org/10.1158/2159-8290.CD-12-0221
15. A.N.A.Monteiro. BRCA1: the enigma of tissue-specific tumor development. Trends Genetics 2003; 19(6):312-5; PMID:12801723; http://dx.doi.org/10.1016/S0168-9525(03)00110-0
16. R.M.Drost, J.Jonkers Preclinical mouse models for BRCA1-associated breast cancer. Br J Cancer 2009; 101:1651-7; PMID:19904273; http://dx.doi.org/10.1038/sj.bjc.6605350
17. J.Dine, C.X.Deng. Mouse models of BRCA1 and their application to breast cancer research. Cancer Metastasis Rev 2012; 32(1-2):25-37
18. P.Kenemans, R.A.Verstraeten, R.H.M.Verheijen. Oncogenic pathways in hSereditary and sporadic breast cancer. Maturitas 2004; 49:34-43; PMID:15351094; http://dx.doi.org/10.1016/j.maturitas.2004.06.005
19. F.Lalloo, D.G.Evans. Familial breast cancer. Clin Genetics 2012; 82:105-14; PMID:22356477; http://dx.doi.org/10.1111/j.1399-0004.2012.01859.x
20. A.S.Whittemore, G.Gong, Itnyre. Prevalence and Contribution of BRCA1 Mutations in Breast Cancer and Ovarian Cancer: Results from Three US. Population-Based Case-Control Studies of Ovarian Cancer. Am J Hum Genetics 1997; 60:496-504; PMID:9042908
21. A.Musolino, M.A.Bella, B.Bortesi, M.Michiare, N.Naldi, P.Zanelli, M.Capelletti, D.Pezzuolo, R.Camisa, M.Savi, et al. BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: A population-based study. Breast 2007; 16:280-92; PMID:17257844; http://dx.doi.org/10.1016/j.breast.2006.12.003
22. J.K.Litton, K.Ready, H.Chen, A.Gutierrez-Barrera, C.J.Etzel, F.Meric-Bernstam, A.M.Gonzales-Angulo, H.Le-Petross, K.Lu, G.N.Hortobagyi, et al. Earlier Age of Onset of BRCA Mutation-Related Cancers in Subsequent Generations. Cancer 2012; 118(2):321-5; PMID:21913181; http://dx.doi.org/10.1002/cncr.26284
23. B.Martinez-Delgado, K.Yanowsky, L.Inglada-Perez, S.Domingo, M.Urioste, A.Osorio, J.Benitez. Genetic anticipation is associated with telomere shortening in hereditary breast cancer. PLoS Genetics 2011; 7(7):e1002182; PMID:21829373; http://dx.doi.org/10.1371/journal.pgen.1002182
24. M.Robson, T.Gilewski, B.Haas, D.Levin, P.Borgen, P.Rajan, Y.Hirschaut, P.Pressman, P.P.Rosen, M.L.Lesser, et al. BRCA-associated breast cancer in young women. J Clin Oncol 1998; 16:1642-9; PMID:9586873
25. D.Stoppa-Lyonnet, Y.Ansquer, H.Dreyfus, C.Gautier, M.Gauthier-Villars, E.Bourstyn, K.B.Clough, H.Magdelenat, P.Pouillart, A.Vincent-Salomon, et al, Institut Curie Breast Cancer Group. Familial invasive breast cancers: worse outcome related to BRCA1 mutations. J Clin Oncol 2000; 18:4053-9; PMID:11118466
26. F.D.Gilliland, N.Joste, P.M.Stauber, W.C.Hunt, R.Rosenberg, G.Redlich, C.R.Key. Biologic characteristics of interval and screen- detected breast cancers. J Natl Cancer Inst 2000; 92(9):743-9; PMID:10793111; http://dx.doi.org/10.1093/jnci/92.9.743
27. F.Eisinger, C.Julian-Reynier, H.Sobol. Re: Biologic characteristics of interval and screen-detected breast cancers. J Natl Cancer Inst 2000; 92(18):1533-4; PMID:10995812; http://dx.doi.org/10.1093/jnci/92.18.1533
28. I.K.Komenaka, B.A.Ditkoff, K.A.Joseph, D.Russo, P.Gorroochurn, M.Ward, E.Horowitz, M.B.El-Tamer, F.R.Schnabel. The Development of Interval Breast Malignancies in Patients with BRCA Mutations. Cancer 2004; 100:2079-83; PMID:15139048; http://dx.doi.org/10.1002/cncr.20221
29. K.Collett I.M.Stefansson, J.Eide, A.Braaten, H.Wang, G.E.Eide, S.O.Thoresen, W.D.Foulkes, L.A.Akslen. A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumors. Cancer Epidemiol Biomarkers Prev 2005; 14(5):1108-12; PMID:15894660; http://dx.doi.org/10.1158/1055-9965.EPI-04-0394
30. S.Ganesan, D.P.Silver, R.Drapkin, R.Greenberg, J.Feunteun, D.M.Livingston. Association of BRCA1 with the inactive X chromosome and XIST RNA. Phil Trans R Soc Lond B 2004; 359:123-8; http://dx.doi.org/10.1098/rstb.2003.1371
31. D.P.Silver, S.D.Dimitrov, J.Feunteun, R.Gelman, R.Drapkin, S.D.Lu, E.Shestakova, S.Velmurugan, N.DeNunzio, S.Dragomir, et al. Further evidence for BRCA1 communication with the inactive X chromosome. Cell 2007; 128:991-1002; PMID:17350581; http://dx.doi.org/10.1016/j.cell.2007.02.025
32. C.Xiao, J.A.Sharp, M.Kawahara, A.R.Davalos, M.J.Difilippantonio, Y.Hu, W.Li, L.Cao, K.Buetow, T.Ried, B.P.Chadwick, C.-X.Deng, B.Panning. The XIST Noncoding RNA functions independently of BRCA1 in X inactivation. Cell 2007; 128:977-89; PMID:17350580; http://dx.doi.org/10.1016/j.cell.2007.01.034
33. G.J.Pageau, L.L.Hall, J.B.Lawrence. BRCA1 does not paint the inactive X to localize XIST RNA but may contribute to broad changes in cancer that impact XIST and Xi heterochromatin. J Cell Biochem 2007; 100:835-50; PMID:17146760; http://dx.doi.org/10.1002/jcb.21188
34. A.Vincent-Salomon, C.Ganem-Elbaz, E.Manie, V.Raynal, X.Sastre-Garau, D.Stoppa-Lyonnet, M.-H.Stern, E.Heard. X inactive-specific transcript RNA coating and genetic instability of the chromosome in BRCA1 breast tumors. Cancer Res 2007; 67(11):5134-40; PMID:17545591; http://dx.doi.org/10.1158/0008-5472.CAN-07-0465
35. S.M.Weakley, H.Wang, Q.Yao, C.Chen. Expression and function of a large non-coding RNA gene XIST in human cancer. World J Surg 2011; 35:1751-6; PMID:21212949; http://dx.doi.org/10.1007/s00268-010-0951-0
36. L.Zheng, L.A.Annab, C.A.Afshari, W.-H.Lee, T.G.Boyer. BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor. PNAS 2001; 98(17):9587-92; PMID:11493692; http://dx.doi.org/10.1073/pnas.171174298
37. C.M.Eakin, M.J.MacCross, G.L.Finney, R.E.Klevit. Estrogen receptor α is a putative substrate for the BRCA1 ubiquitin ligase. PNAS 2007; 104(14):5794-9; PMID:17392432; http://dx.doi.org/10.1073/pnas.0610887104
38. Y.Ma, P.Katiyar, L.P.Jones, S.Fan, Y.Zhang, P.A.Furth, E.M.Rosen. The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells. Mol Endocrinol 2006; 20(1):14-34; PMID:16109739; http://dx.doi.org/10.1210/me.2004-0488
39. S.J.Elledge, A.Amon. The BRCA1 suppressor hypothesis: An explanation for the tissue-specific tumor development in BRCA1 patients. Cancer Cell 2002; 1:129-32; PMID:12086871; http://dx.doi.org/10.1016/S1535-6108(02)00041-7
40. G.Luo, I.M.Santoro, L.D.McDaniel, I.Nishijima, M.Mills, H.Youssoufian, H.Vogel, R.A.Schultz, A.Bradley. Cancer predisposition caused by elevated recombination in Bloom mice. Nat Genetics 2000; 26(4):424-9; PMID:11101838; http://dx.doi.org/10.1038/82548
41. M.E.Dolle, W.K.Snyder, J.A.Gossen, P.H.Lohman, J.Vijg. Distinct spectra of somatic mutations accumulated with age in mouse heart and small intestine. PNAS 2000; 97(15):8403-8; PMID:10900004; http://dx.doi.org/10.1073/pnas.97.15.8403
42. H.Vrieling. Mitotic maneuvers in the light. Nat Genetics 2001; 28:101-2; PMID:11381245; http://dx.doi.org/10.1038/88794
43. C.Shao, P.J.Stambrook, J.A.Tischfield. Mitotic recombination is suppressed by chromosomal divergence in hybrids of distantly related mouse strains. Nat Genetics 2001; 28(2):169-72; PMID:11381266; http://dx.doi.org/10.1038/88897
44. D.Holt, M.Dreimanis, M.Pfeiffer, F.Firgaira, A.Morley, D.Turner. Interindividual Variation in Mitotic Recombination. Am J Hum Genetics 1999; 65:1423-7; PMID:10521309; http://dx.doi.org/10.1086/302614
45. R.Fridlich, D.Annamalai, R.Roy, G.Bernheim, S.N.Powell. BRCA1 and BRCA2 protect against oxidative DNA damage converted into double-strand breaks during DNA replication. DNA Repair 2015; 30:11-20; PMID:25836596; http://dx.doi.org/10.1016/j.dnarep.2015.03.002
46. N.Rahman, M.R.Stratton. The genetics of breast cancer susceptibility. Anu Rev Genet 1998; 32:95-121; http://dx.doi.org/10.1146/annurev.genet.32.1.95
47. E.Honrado, J.Benitez, J.Palacios. The molecular pathology of hereditary breast cancer: genetic testing and therapeutic implications. Modern Pathol 2005; 18:1305-20; PMID:15933754; http://dx.doi.org/10.1038/modpathol.3800453
48. P.M.Campeau, W.D.Foulkes, M.D.Tischkowitz. Hereditary breast cancer: new genetic developments, new therapeutic avenues. Hum Genet 2008; 124:31-42; PMID:18575892; http://dx.doi.org/10.1007/s00439-008-0529-1
49. T.F.Lane, C.Deng, A.Elson, M.S.Lyu, C.A.Kozak, P.Leder. Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice. Genes Dev 1995; 9:2712-22; PMID:7590247; http://dx.doi.org/10.1101/gad.9.21.2712
50. M.Kubista, M.Rosner, E.Kubista, G.Bernaschek, M.Hengstschlager. Brca1 regulates in vitro differentiation of mammary epithelial cells. Oncogene 2002; 21:4747-56; PMID:12101413; http://dx.doi.org/10.1038/sj.onc.1205580
51. W.D.Foulkes. BRCA1 functions as a breast stem cell regulator. J Med Genet 2004; 41:1-5; PMID:14729816; http://dx.doi.org/10.1136/jmg.2003.013805
52. F.C.Martins, D.Subhajyoti, V.Almendro, M.Gonen, S.Y.Park, J.L.Blum, W.Herlihy, G.Ethington, S.J.Schnitt, N.Tung, J.E.Garber, K.Fetten, F.Michor, K.Polyak. Evolutionary Pathways in BRCA1-Associated Breast Tumors. Cancer Discov 2012; 2:503-11; PMID:22628410; http://dx.doi.org/10.1158/2159-8290.CD-11-0325
53. L.R.Cavalli, B.Singh, C.Isaacs, R.B.Dickson, B.R.Haddad. Loss of heterozygosity in normal breast epithelial tissue and benign breast lesions in BRCA1/2 carriers with breast cancer. Cancer Genetics Cytogenetics 2004; 149:38-43; PMID:15104281; http://dx.doi.org/10.1016/S0165-4608(03)00282-6
54. C.L.Clarke, J.Sandle, A.A.Jones, A.Sofronis, N.R.Patani, S.R.Lakhani. Mapping loss of heterozygosity in normal human breast cells from BRCA1/2 carriers. British J Cancer 2006; 95:515-9; PMID:16880780; http://dx.doi.org/10.1038/sj.bjc.6603298
55. T.A.King, W.Li, E.Brogi, C.J.Yee, M.L.Gemignani, N.Olvera, D.A.Levine, L.Norton, M.E.Robson, K.Offit, P.I.Borgen, J.Boyd. Heterogenic Loss of the Wild-Type BRCA Allele in Human Breast Tumorigenesis. Annals Surg Oncol 2007; 14(9):2510-8; PMID:17597348; http://dx.doi.org/10.1245/s10434-007-9372-1
56. C.Baldeyron, E.Jacquemin, J.Smith, C.Jacquemont, I.De Oliveira, S.Gad, J.Feunteun, D.Stoppa-Lyonnet, D.Papadopoulo. A single mutated BRCA1 allele leads to impaired fidelity of double strand break end-joining Oncogene 2002; 21(9):1401; PMID:11857083; http://dx.doi.org/10.1038/sj.onc.1205200
57. K.Rennstam, A.Ringberg, H.E.Cunliffe, H.Olsson, G.Landberg, I.Hedenfalk. Genomic alterations in histopathologically normal breast tissue from BRCA1 mutation carriers may be caused by BRCA1 haploinsufficiency. Genes Chromosomes Cancer 2010; 49(1):78; PMID:19839046; http://dx.doi.org/10.1002/gcc.20723
58. H.Konishi, M.Mohseni, A.Tamaki, J.P.Garay, S.Croessmann, S.Karnan, A.Ota, H.Y.Wong Y.Konishi, B.Karakas, et al. Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells, PNAS 2011; 108(43):17773-9; PMID:21987798; http://dx.doi.org/10.1073/pnas.1110969108
59. M.Sedic, A.Skibinski, N.Brown, M.Gallardo, P.Mulligan, P.Martinez, P.J.Keller, E.Glover, A.L.Richardson, J.Cowan, et al. Haploinsufficiency for BRCA1 leads to cell-type-specific genomic instability and premature senescence. Nat Commun 2015 6:7505; http://dx.doi.org/10.1038/ncomms8505
60. S.Fan, R.Yuan, Y.X.Ma, Q.Meng, I.D.Goldberg, E.M.Rosen. Mutant BRCA1 genes antagonize phenotype of wild-type BRCA1. Oncogene 2001; 20, 8215-35; PMID:11781837; http://dx.doi.org/10.1038/sj.onc.1205033
61. Q.Ye, Y.F.Hu, H.Zhong, A.C.Nye, A.S.Belmont, R.Li. BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations. J Cell Biol 2001; 155(6):911-21; PMID:11739404; http://dx.doi.org/10.1083/jcb.200108049
62. Y.Miki, J.Swensen, D.Shattuck-Eidens, P.A.Futreal, K.Harshman, S.Tavtigian, Q.Liu, C.Cochran, L.M.Bennett, W.Ding, et al. ‘A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1’. Science 1994; 266 (5182):66-71; PMID:7545954; http://dx.doi.org/10.1126/science.7545954
63. C.A.Pettgrew, J.D.French, J.M.Saunus, S.L.Edwards, A.V.Sauer, C.E.Smart, T.Lundstrom, C.Weisner, A.B.Spurdle, J.A.Rothnagel, et al. Identification and functional analysis of novel BRCA1 transcripts, including mouse BRCA1-Iris and human pseudo-BRCA1. Breast Cancer Res Treat 2008; 119(1):239-47; PMID:19067158; http://dx.doi.org/10.1007/s10549-008-0256-2
64. A.Romero, F.Garcia-Garcia, I.Lopez-Perolio, G.Ruiz de Garibay, J.A.Garcia-Saenz, P.Garre, P.Ayllon, E.Benito, J.Dopazo, E.Diaz-Rubio, et al. BRCA1 alternative splicing landscape in breast tissue samples. BMC Cancer 2015; 15:219; PMID:25884417; http://dx.doi.org/10.1186/s12885-015-1145-9
65. S.Pathania, S.Bade, M.Le Guillou, K.Burke, R.Reed, C.Bowman-Colin, Y.Su, D.T.Ting, K.Polyak, A.L.Richardson, et al. BRCA1 haploinsufficiency for replication stress suppression in primary cells. Nat Commun 2014; 5:5396; http://dx.doi.org/10.1038/ncomms6496
66. T.A.Proia, P.J.Keller, P.B.Gupta, I.Klebba, A.D.Jones, M.Sedic, H.Gilmore, N.Tung, S.P.Naber, S.Schnitt, et al. Genetic Predisposition Directs Breast Cancer Phenotype by Dictating Progenitor Cell Fate. Cell Stem Cell 2011; 8:149-63; PMID:21295272; http://dx.doi.org/10.1016/j.stem.2010.12.007
67. P.S.Larson, B.L.Schlechter, A.de las Morenas, J.E.Garber, L.A.Cupples, C.L.Rosenberg. Allele imbalance, or loss of heterozygosity, in normal breast epithelium of sporadic breast cancer cases and BRCA1 gene mutation carriers is increased compared with reduction mammoplasty tissues. J Clin Oncol 2005; 23(34):8613-9; PMID:16314623; http://dx.doi.org/10.1200/JCO.2005.02.1451
68. I.Cousineau, A.Belmaaza. BRCA1 Haploinsufficiency but not Heterozygosity for a BRCA1-truncating Mutation, Deregulates Homologous Recombination. Cell Cycle 2007; 6(8):962-71; PMID:17404506; http://dx.doi.org/10.4161/cc.6.8.4105
69. M.D’Errico, T.Lemma, A.Calcagnile, L.P.De Santis, E.Dogliotti. Cell type and DNA damage specific response of human skin cells to environmental agents. Mutation Res 2007; 614:37-47; http://dx.doi.org/10.1016/j.mrfmmm.2006.06.009
70. S.Liu, C.Ginestier, E.Charafe-Jauffret, H.Foco, C.G.Kleer, S.D.Merajver, G.Dontu, M.S.Wicha. BRCA1 regulates human mammary stem/progenitor cell fate. PNAS 2008; 105(5):1680-5; PMID:18230721; http://dx.doi.org/10.1073/pnas.0711613105
71. E.Lim, F.Vaillant, D.Wu, N.C.Forrest, B.Pal, A.H.Hart, M.L.Asselin-Labat, D.E.Gyorki, T.Ward, A.Partanen, et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med 2009; 15(8):907-13; PMID:19648928; http://dx.doi.org/10.1038/nm.2000
72. T.A.Proia, P.J.Keller, P.B.Gupta, I.Klebba, A.D.Jones, M.Sedic, H.Gilmore, N.Tung, S.P.Naber, S.Schnitt, et al. Genetic Predisposition Directs Breast Cancer Phenotype by Dictating Progenitor Cell Fate. Cell Stem Cell 2011; 8:149-63; PMID:21295272; http://dx.doi.org/10.1016/j.stem.2010.12.007
73. P.J.Keller, L.M.Arendt, A.Skibinski, T.Logvinenko, I.Klebba, S.Dong, A.E.Smith, A.Prat, C.M.Perou, H.Gilmore, et al. Defining the cellular precursors to human breast cancer. PNAS 2012; 109(8):2772-77; PMID:21940501; http://dx.doi.org/10.1073/pnas.1017626108